SCHEMBL570229

SCHEMBL570229

C[Si](C)(C)c1ccc(Br)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.50
ALDH1A1 P00352 5/20 0.45
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
IDO1 P14902 1/20 0.38
ALOX15 P16050 2/20 0.38
MAPK1 P28482 2/20 0.38
TDP1 Q9NUW8 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
GAA P10253 2/20 0.34
TSHR P16473 3/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
NOS1 P29475 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
DGAT1 O75907 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
NPC1 O15118 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8349228 0.97 CYP2A6 (0.47) CYP2A6ALDH1A1NR1H2NR1H3IDO1
SCHEMBL4874529 0.92 ALDH1A1 (0.48) CYP2A6ALDH1A1NR1H2NR1H3MAPK1
SCHEMBL15678827 0.85 ALDH1A1 (0.42) CYP2A6ALDH1A1MAPK1GAATSHR
SCHEMBL19624747 0.85 CYP2A6 (0.36) CYP2A6ALDH1A1NR1H2NR1H3IDO1
SCHEMBL15906973 0.85 CYP2A6 (0.36) CYP2A6ALDH1A1NR1H2NR1H3IDO1
SCHEMBL586534 0.83 NR1H2 (0.50) NR1H2NR1H3GAAHPGD
SCHEMBL11749536 0.82 LMNA (0.59) ALDH1A1MAPK1CA1CA2CES2
SCHEMBL8915096 0.81 CYP2A6 (0.50) CYP2A6ALDH1A1NR1H2NR1H3IDO1
SCHEMBL15906942 0.78 ALDH1A1 (0.42) ALDH1A1MAPK1TDP1TSHRCES2
SCHEMBL9754473 0.77 CYP2A6 (0.44) CYP2A6ALDH1A1IDO1ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120040632-A Polydiphenylacetylene derivative capable of rapidly detecting nitrobenzene explosives, synthesis method and application thereof 浙江大学绍兴研究院 2025-05-27 CN claimed
CN-119874533-A Synthesis method of 3, 5-difluoro-4-amino-4' -iodobiphenyl 联化昂健医药科技(上海)有限公司 2025-04-25 CN claimed
US-12428429-B2 Amine compound and organic light-emitting diode including same SFC CO., LTD. (KR) 2025-09-30 US disclosed
CN-120040632-A Polydiphenylacetylene derivative capable of rapidly detecting nitrobenzene explosives, synthesis method and application thereof 浙江大学绍兴研究院 2025-05-27 CN disclosed
CN-119954646-A Boron radical mediated nickel catalyzed C (sp3)-C(sp2) Cross coupling process 合肥工业大学 2025-05-09 CN disclosed
CN-119874533-A Synthesis method of 3, 5-difluoro-4-amino-4' -iodobiphenyl 联化昂健医药科技(上海)有限公司 2025-04-25 CN disclosed
CN-119874533-A Synthesis method of 3, 5-difluoro-4-amino-4' -iodobiphenyl 联化昂健医药科技(上海)有限公司 2025-04-25 CN disclosed
CN-119822988-A Photochemical synthesis method of formanilide compound 合肥工业大学 2025-04-15 CN disclosed
CN-115362151-B Arylpiperidines as monoacylglycerol lipase modulators 詹森药业有限公司 2025-02-11 CN disclosed
EP-4116297-B1 CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING SFC CO LTD (KR) 2025-01-08 EP disclosed
EP-3654395-B9 ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY SFC CO LTD (KR) 2024-11-06 EP disclosed
WO-1996040681-A1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1996-12-19 WO disclosed
EP-0742222-A2 Novel silacyclohexane compounds, preparation thereof, liquid crystal compositions comprising the same, and liquid crystal devices comprising the composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 1996-11-13 EP disclosed
EP-0722959-A2 Highly oxygen-permeable heat-resistant material Menicon Co., Ltd. (JP) 1996-07-24 EP disclosed
US-5175243-A Reaction of a sulfur source and a dihalobenzene in cyclic amide PHILLIPS PETROLEUM COMPANY (US) 1992-12-29 US disclosed
EP-0486014-A1 Process for preparing arylene sulfide polymers PHILLIPS PETROLEUM COMPANY (US) 1992-05-20 EP disclosed
US-5026894-A Compound for use in the synthesis of semiconducting polymers with perpendicularly arranged cores and method of synthesizing said compound UNIVERSITY OF SOUTH CAROLINA (US) 1991-06-25 US disclosed
EP-0403713-A1 Novel acetylcholinesterase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1990-12-27 EP disclosed
US-4609651-A ANTIGESTATION, ANTIMINERALOCORTICOID SCHERING AKTIENGESELLSCHAFT (DE) 1986-09-02 US disclosed
EP-0147361-A2 11-Beta-aryl-estradienes, their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12428429-B2 Amine compound and organic light-emitting diode including same MAOA, AOC2, MAOB CYP2A6 1843/4885ALDH1A1 93/4885NR1H2 1725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.